Related references
Note: Only part of the references are listed.Targeted therapy strategies against SARS-CoV-2 cell entry mechanisms: A systematic review of in vitro and in vivo studies
Simin Seyedpour et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2021)
Long-Term Nonclinical Pulmonary Safety Assessment of Afrezza, a Novel Insulin Inhalation Powder
Stephanie F. Greene et al.
TOXICOLOGIC PATHOLOGY (2021)
Discovery of New Fusion Inhibitor Peptides against SARS-CoV-2 by Targeting the Spike 52 Subunit
Mahmoud Kandeel et al.
BIOMOLECULES & THERAPEUTICS (2021)
Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease
Aaron Waxman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
The risk factors associated with MERS-CoV patient fatality: A global survey
Jamal Ahmadzadeh et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2020)
Small Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Fusion by Targeting Cavities on Heptad Repeat Trimers
Mahmoud Kandeel et al.
BIOMOLECULES & THERAPEUTICS (2020)
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
Timothy P. Sheahan et al.
NATURE COMMUNICATIONS (2020)
SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues
Carly G. K. Ziegler et al.
CELL (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes
Waradon Sungnak et al.
NATURE MEDICINE (2020)
Application of Fragment-Based Drug Discovery to Versatile Targets
Qingxin Li
FRONTIERS IN MOLECULAR BIOSCIENCES (2020)
Antibody-Based Immunotherapeutic Strategies for COVID-19
Jamal Hussen et al.
PATHOGENS (2020)
General Purpose Water Model Can Improve Atomistic Simulations of Intrinsically Disordered Proteins
Parviz Seifpanahi Shabane et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2019)
A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike
Shuai Xia et al.
SCIENCE ADVANCES (2019)
Potent MERS-CoV Fusion Inhibitory Peptides Identified from HR2 Domain in Spike Protein of Bat Coronavirus HKU4
Shuai Xia et al.
VIRUSES-BASEL (2019)
Towards a solution to MERS: protective human monoclonal antibodies targeting different domains and functions of the MERS-coronavirus spike glycoprotein
Ivy Widjaja et al.
EMERGING MICROBES & INFECTIONS (2019)
Structure-guided design of potent and permeable inhibitors of MERS coronavirus 3CL protease that utilize a piperidine moiety as a novel design element
Anushka C. Galasiti Kankanamalage et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Rigid amphipathic fusion inhibitors demonstrate antiviral activity against African swine fever virus
Astghik Hakobyan et al.
JOURNAL OF GENERAL VIROLOGY (2018)
Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2
Wenfei Song et al.
PLOS PATHOGENS (2018)
Potent peptidic fusion inhibitors of influenza virus
Rameshwar U. Kadam et al.
SCIENCE (2017)
Identification, synthesis and evaluation of SARS-CoV and MERS-CoV 3C-like protease inhibitors
Vathan Kumar et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2016)
Peptide therapeutics: current status and future directions
Keld Fosgerau et al.
DRUG DISCOVERY TODAY (2015)
Discovery of Imidazopyridine Derivatives as Highly Potent Respiratory Syncytial Virus Fusion Inhibitors
Song Feng et al.
ACS MEDICINAL CHEMISTRY LETTERS (2015)
Cell-Penetrating Peptides Selectively Cross the Blood-Brain Barrier In Vivo
Sofie Stalmans et al.
PLOS ONE (2015)
Co-Expression of Foreign Proteins Tethered to HIV-1 Envelope Glycoprotein on the Cell Surface by Introducing an Intervening Second Membrane-Spanning Domain
Hongyun Wang et al.
PLOS ONE (2014)
Middle East respiratory syndrome coronavirus (MERS-CoV) entry inhibitors targeting spike protein
Shuai Xia et al.
VIRUS RESEARCH (2014)
Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor
Lu Lu et al.
NATURE COMMUNICATIONS (2014)
Progress in the Identification of Dengue Virus Entry/Fusion Inhibitors
Carolina De La Guardia et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Treatment with interferon-α2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques
Darryl Falzarano et al.
NATURE MEDICINE (2013)
BeAtMuSiC: prediction of changes in protein-protein binding affinity on mutations
Yves Dehouck et al.
NUCLEIC ACIDS RESEARCH (2013)
From in silico target prediction to multi-target drug design: Current databases, methods and applications
Alexios Koutsoukas et al.
JOURNAL OF PROTEOMICS (2011)
Identification of a minimal peptide derived from heptad repeat (HR) 2 of spike protein of SARS-CoV and combination of HR1-derived peptides as fusion inhibitors
I-Jung Liu et al.
ANTIVIRAL RESEARCH (2009)
Target identification using drug affinity responsive target stability (DARTS)
Brett Lomenick et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Fusion core structure of the severe acute respiratory syndrome coronavirus (SARS-CoV): In search of potent SARS-CoV entry inhibitors
Ling-Hon Matthew Chu et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
A novel approach using functional peptides for efficient intestinal absorption of insulin
Mariko Morishita et al.
JOURNAL OF CONTROLLED RELEASE (2007)
Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein
Bruno Sainz et al.
VIRUS RESEARCH (2006)
The coronavirus spike protein is a class I virus fusion protein: Structural and functional characterization of the fusion core complex
BJ Bosch et al.
JOURNAL OF VIROLOGY (2003)
Share Paper
